id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2015-0794-0031,EPA,EPA-HQ-OPP-2015-0794,Registration Review: Draft Ecological and/or Human Health Risk Assessments,Notice,,2016-09-19T04:00:00Z,2016,9,,,2017-02-16T02:02:35Z,2016-22506,0,0,0900006482225c5a
EPA-HQ-OPP-2015-0794-0005,EPA,EPA-HQ-OPP-2015-0794,"Registration Reviews: Atrazine, Simazine, and Propazine; Draft Ecological Risk Assessments; Extension of Comment Period",Notice,Extension of Comment Period,2016-07-06T04:00:00Z,2016,7,2016-07-07T04:00:00Z,2016-10-06T03:59:59Z,2017-02-16T02:00:29Z,2016-16021,0,0,090000648208bdec
EPA-HQ-OPP-2015-0794-0003,EPA,EPA-HQ-OPP-2015-0794,"Draft Ecological Risk Assessments: Atrazine, Simazine, and Propazine Registration Review",Notice,Request for Comments,2016-06-06T04:00:00Z,2016,6,2016-06-06T04:00:00Z,2016-10-06T03:59:59Z,2016-10-27T01:00:37Z,2016-13299,0,0,0900006482014756
EPA-HQ-OPP-2015-0794-0002,EPA,EPA-HQ-OPP-2015-0794,"Draft Human Health and Ecological Risk Assessments: Aldicarb, Bensulide, Coumaphos, Ethalfluralin, and Pirimiphos-methyl  Registration Review",Notice,,2016-04-26T04:00:00Z,2016,4,,,2016-04-26T16:13:40Z,2016-09732,0,0,0900006481f8ddf6
EPA-HQ-OPP-2015-0794-0001,EPA,EPA-HQ-OPP-2015-0794,Human Health and Ecological Risk Assessments Draft; Registration Review,Notice,,2016-01-06T05:00:00Z,2016,1,,,2016-01-06T15:19:06Z,2015-33298,0,0,0900006481dec80b